Dennewill James Robert Jr. 4
4 · SpyGlass Pharma, Inc. · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
SpyGlass (SGP) COO Dennewill Receives 105,000-Share Award
What Happened
Dennewill James Robert Jr., Chief Operating Officer of SpyGlass Pharma, was granted a derivative award covering 105,000 shares on February 5, 2026. The Form 4 reports the acquisition price as $0.00 (grant), and the transaction is reported as an award/grant (code A) rather than an open-market purchase or sale. This is a compensation-related award (not an immediate sale) that vests over time per the company plan.
Key Details
- Transaction date: February 5, 2026; filing date: February 9, 2026 (timely — filed on the second business day after the transaction).
- Amount: 105,000 shares (derivative securities); reported acquisition price: $0.00.
- Shares owned after the transaction: not specified in the provided filing details.
- Vesting (footnote): Vesting Commencement Date = Feb 5, 2026. 25% of the option vests on the one-year anniversary (Feb 5, 2027), then 1/48th of the total shares vests monthly thereafter. The footnote explicitly refers to these as options subject to continued service.
- No 10b5-1 plan, tax-withholding sale, or immediate disposition was reported.
Context
This filing reflects a time-based equity award (options) intended as executive compensation and retention — the recipient does not receive all shares immediately; they vest over a multi-year schedule. Because it’s an award (not a purchase), it’s primarily a compensation disclosure rather than a personal investment signal.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-02-05+105,000→ 105,000 totalExercise: $16.00Exp: 2036-02-05→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 5, 2026.